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Abstract 
 
The impetus for the development of oral dosage forms with extended oesophageal residence time is 
provided by the strong demand for localised therapies. In parallel, there is considerable demand for 
the development of technologies that improve the ease of swallowing by minimising oesophageal 15 
transit time. Solid oral dosage forms that are coated with a bioadhesive material represent one of 
the approaches towards either of these goals. This study provides a preliminary assessment of the in 
vitro oesophageal retention characteristics of several widely utilised pharmaceutical coating 
materials. To this end, a previously described apparatus has been used to measure the force 
required to pull a coated disc-shaped model tablet across a specified section of excised oesophageal 20 
tissue. Of the materials tested, the well-studed mucoadhesive polymer sodium alginate was not only 
found to be associated with significant oesophageal adhesion properties but also to display the 
capability to form self-repairing bioadhesive coatings that reformed following damage. 
Hydroxypropylmethylcellulose also exhibited bioadhesive behaviour but that was less pronounced to 
that of the alginates.  The blending of hydroxypropylmethylcellulose with plasticiser or with low 25 
molecular weight polymers and surfactants did not influence bioadhesive behaviour significantly. 
 2 
Low molecular weight water soluble polymers, were found to behave similarly to the uncoated glass 
control disc. Polysorbates exhibited bioadhesion behaviour that was majorly influenced by the 
incorporated surfactant. The insoluble polymer ethylcellulose, and the relatively lipophilic surfactant 
sorbitan monooleate were seen to move over oesophageal tissue more readily than the uncoated 30 
glass disc, suggesting that these may be suitable for investigation as coatings for easy-to-swallow 
solid oral dosage forms. 
 
Keywords: oesophageal adhesion, easy-to-swallow, mucoadhesion, non-adhesive coatings. 
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1. Introduction 
 
The adhesion of solid formulations to the oesophagus during swallowing has been widely implicated 
in medication-induced injury to this organ.  A high local concentration of mucosal irritants (e.g. 
emepronium bromide, apple-cider vinegar, alendronate sodium, tetracycline, potassium chloride) 40 
within the oesophagus may lead to oesophageal damage (Hill et al., 2005; Jaspersen, 2000; Ueda et 
al., 2011).  In addition, the extended retention of therapeutic formulations in the oesophagus may 
impact on the bioavailability and the pharmacokinetics profile of the active. Formulation size, shape 
and surface characteristics have been identified as factors that influence the adhesion of dosage 
forms in the oesophagus during swallowing (Channer and Virjee, 1985; Marvola et al., 1982; Perkins 45 
et al., 2001).  
 
The  adhesion of solid dosage forms to the oesophagus is often desirable, however, since it may 
provide the means for anchoring formulations designed for the local treatment of gastrooesphageal 
reflux disease (Batchelor et al., 2002) or for pain and inflammation (Mako et al., 2009), or for 50 
delivering diagnostic agents (Collaud et al., 2007).   
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Towards the development of solid oral dosage forms with fine-tuned bioadhesion characteristics, 
the aim of this study is to provide an in vitro assessment of the oesophageal retention behaviour of a 
range of pharmaceutical coating materials. The bioadhesion evaluation is performed by means of an 
in vitro apparatus (Smart et al. 2013), in which adhesive interactions are assessed in terms of the 55 
force needed to pull a disc coated with a test material over a flattened section of oesophageal 
mucosa under physiologically relevant shear stress conditions.  
 
2. Materials and methods 
 60 
2.1 Materials  
Hydroxypropylmethylcellulose (HPMC), under the trade names Pharmacoat 615 was supplied by 
Harke Group, Muelheim an der Ruhr, Germany;  The Pluronic™ copolymers F127, F98  and F38 were 
supplied by BASF PLC, Cheadle, Cheshire. Poly(ethylene glycol) (PEG) 6,000 MW grade (PEG) and 
Paraffin wax (high melting point, ca. 60°C) was purchased from B.D.H Chemicals Ltd, Poole. 65 
Polyethylene glycol (PEG) (1,450 mw grade and 200 mw grade), Gelatin (type B, from bovine skin), 
sodium alginate (medium viscosity grade from Mactocystis pyrifera)  fluorescein, Type III partially 
purified mucin, from porcine stomach, triacetin and sorbitan monopalmitate (Span 40)  purchased 
from Sigma-Aldrich Chemical Company, Poole, Dorset. Polyvinyl alcohol (PVA) 15,000 mw grade and 
ethylcellulose (Ethocel, 10 mPas) were supplied by Fluka Chemicals, Gillingham. LustreClear™ (a 70 
microcrystalline cellulose/carrageenan/polyethylene oxide based coating), FMC Biopolymer, 
Brussels, Belgium.  
Poly(ethylene oxide), under trade name PolyOx™ (NF grade, NlO) were supplied by Dow chemical 
company, Belfast. 
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2.2 Preparation of solutions 
 4 
 
Dispersions of HPMC (7% w/w), PEG (15 %w/w), sodium alginate (1.5% w/w),  gelatin (8% w/w), FI27 
(10% w/w), Lustraclear™ (9% w/w)  and PVA (4% w/w) were all prepared by adding the appropriate 
mass of polymer to rapidly  vortexing (magnetic stirrer) de-ionised water. Mixes were prepared in 80 
the proportions of HPMC 7.5% / triacetin 1.5%; HPMC 3% / triacetin 1.5%; HPMC 7.5% PEG 200 
1.5%; HPMC 3.75%, triacetin 1.5%, F127 3.75%; PVA 4%, F127 1%. Ethyl cellulose (5% w/w) and 
sorbitan monopalmitate (7% w/w) were prepared by dissolving in ethanol and isopropanol 
respectively. All solutions were stored with stirring overnight before use.  
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Simulated saliva was prepared by dissolving 0.9 % sodium chloride solution in deionised water and 
then adding 0.5% gastric mucin. 
 
Test discs were prepared by casting films from the aqueous polymer solutions using a spin casting 
technique. The majority of the films were spun at a speed of ca. 1000 rpm for 30 seconds, however, 90 
the more viscous solutions of HPMC blends and sodium alginate required a higher rotation speed of 
ca. 2000 rpm for 50 seconds. The films were then air-dried (at ambient temperature) and weighed; 
further applications were applied until a dry constant weight of between 1.50 - 2.00 mg was 
achieved. Paraffin wax and PEG were melted over a beaker of boiling water. Once molten the glass 
discs were coated by dipping the surface of each into the molten wax using tweezers and were then 95 
allowed to set at room temperature. The films were stored in a dessicator over silica gel and used 
within 1 week to avoid any discrepancies due physical ageing. 
 
The apparatus consisted of the porcine oesophageal mucoadhesion test system described by Smart 
et al. (2013). Effectively the disc coated with the test material on its lower surface and with a 2 g 100 
weight placed on the upper surface is pulled off a PTFE ‘non-stick’ launch then pulled for 290 s 
across a distance of 59.5 mm on a flat section of frozen and thawed pig oesphageal mucosa at a 10° 
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angle with a flow of simulated saliva (1 mL min−1) along the tissue. The force required to move the 
disc was recorded, and only one test was completed on each tissue. To take into account tissue 
variances an identical uncoated roughened glass disc was tested on each tissue before adhesion 105 
testing with the coated test disc. Each material was tested six times on six different tissues and the 
corresponding values of the roughened glass controls are also included for each material.  
Statistical differences were tested using Analysis of Variance with a Multiple comparison - Tukey's 
HSD, p < 0.05. 
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3. Results 
 
This apparatus measures the resistance to movement of the test disc across the oesphageal mucosa. 
Two parameters were evaluated: the Maximum Detachment Force (greatest resistance force to 
movement across the tissue; most often this corresponded with the force associated with resistance 115 
to initiate movement across the tissue); and, the work done (area under the force-distance curve 
over 59.5 mm. To account for differences related to tissue topography, measurements were taken 
for the test material and for the uncoated plate and then normalised by dividing by the values 
obtained for the uncoated glass disc on the same tissue sample. The experimental protocol allowed 
the determination of the adhesion and detachment ratios.  120 
 
Bioadhesion data for the range of coatings tested is presented on Table 1 and Fig. 2. Of the range of 
coating materials that have been evaluated sodium alginate and HPMC were found to exhibit the 
greatest resistance to movement. Interestingly, one of the least adhesive materials was 
Lustraclear™, which exhibited an initial detachment force that was significantly higher than that 125 
seen for the glass plate control.  Coatings of PVA or gelatin exhibited behavior that was very similar 
to that of the uncoated glass plate.  The higher molecular weight polyethylene oxide (PolyOx) was 
characterized by a high resistance to movement, while the structurally related lower molecular 
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weight  PEGs behaved similarly to the glass plate controls (Table 2, Fig 3). The mode of deposition 
(from the melt or from solution) of the PEG 1450 coating had little effect on the resistance-to-130 
movement value measured. 
 
 Of the three Pluronics tested, only F127 showed a significantly larger adhesion ratio than the 
control (Table 3, Fig 4), while the PVA F127 mix exhibited bioadhesion behaviour that was akin to 
that of the glass plate. F38 was characterized by its very low resistance to the onset of movement, 135 
as were the water insoluble materials ethylcellulose and sorbitan monooleate, both of displayed 
lower resistance to movement than the glass plate (Table 4, Fig. 5).  
 
The mixing of HPMC with triacetin (a plasticizer), a pluronic and PEG did not induce a significant 
effect on the measured biadhesive properties as compared with those determined for HPMC alone 140 
(Table 5, Fig. 6). 
 
4. Discussion 
 
The aim of this study was to use a previously developed test system to evaluate the adhesion of solid 145 
oral dosage form coatings to oesophageal mucosa at physiologically relevant shear stresses.  In a 
typical force-distance plot, there would be an initial increase (from zero) in the force measured as 
tension is applied to the disc. If adhesion is similar to that of controls, the force measured 
corresponds to the frictional force of pulling the disc across the mucosa. Bioadhesion is deemed to 
occur when there is a marked increase in the force measured relative to that for the control. A 150 
reduction in the force required to move the coated plate relative to that needed to move the 
roughened glass plate identifies the coating material as non –adhesive/lubricating.  
 
In accord with findings from a previous study, sodium alginate is a material that becomes 
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bioadhesive on hydration (Mortazavi and Smart 1994, Smart 2014). In addition to exhibiting 155 
significant bioadhesion, if dislodged this material was seen to self-repair the adhesive joint by re-
adhering at the next contact point.  
 
In accord with previous reports and owing to the absence of ionisable structural moieties, HPMC, 
which is employed widely as a tablet coating and also as a bioadhesive in some buccal formulations 160 
(e.g. Suscard BuccalTM), is confirmed to be a weaker oesophageal bioadhesive than sodium alginate 
(Smart 2014). Gelatin, a protein that is the main component of many soft and hard capsules, 
exhibited little evidence of bioadhesive behaviour. Also in accord with previous reports (Mortazavi 
and Smart 1995), PVAs, the hydrophilic non-ionic polymers often used as tablet coatings, were found 
to behave in a similar fashion to the uncoated disc control.  LustreClear™, the microcrystalline 165 
cellulose/carrageenan/polyethylene oxide based coating that is marketed as a coating with an 
‘unparalleled ease of swallowing’, behaved similarly in that it showed some bioadhesive properties 
on application to the tissue (i.e. some force was required to start to move the plate) but the average 
work done to pull the plate across the oesophagus was not significantly different from that obtained 
for the uncoated glass plate. This bioadhesive behaviour may be explained in terms of the 170 
mucoadhesive component (carrageenan; Mortazavi and Smart 1995) of the coating formulation. 
 
Characterised by the dual capability to mask materials for parenteral administration and to prevent 
bacterial biofilm formation (Arciola et al 2012), PEGylation may also be reasonably assumed to result 
in materials that hydrate rapidly and form a lubricating ‘slippery mucilage’ between the disc and 175 
mucosa. Under the testing protocol employed in this study, however, the behaviour of PEGs was 
little different to that of the uncoated disc (Table 2, Fig. 3). It is assumed that this behavior is 
consequent to the PEG coating being rapidly removed in an aqueous test environment. Relatively 
high molecular weight polytheylene oxide coatings, which have been used as mucoadhesives 
(Mortazavi and Smart 1995), required an initial strong detachment force to get the disc moving but 180 
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adhesion ratios were similar to those of the glass-plate control. Blending the PluronicTM F127 with a 
low molecular weight water soluble polymer, such as PVA, reduced the resistance to initial 
movement to close to that of the glass plate control. Since PluronicTM surfactants consist of two 
blocks of hydrophilic polyoxethylene flanking a central hydrophobic polyoxypropylene block, it may 
be assumed that in aqueous environments the hydrophilic components orientate themselves such 185 
that that they become projected outwards from the film to form a hydrated lubricating coating. F38 
(average molecular weight, 4700; HLB, 16.1) exhibited bioadhesion behaviour that was 
insignificantly different to that of the glass plate control. It is possible that it this material becomes 
rapidly removed from the glass substrate that it coats.  F98 (average molecular weight, 13000;  HLB, 
16) showed some adhesion, notably in the initial detachment force. The less hydrophilic F127 190 
(average molecular weight, 12,600;  HLB, 13.8) exhibited significant bioadhesive properties, 
indicating its unsuitability for use as an ‘easy to swallow’ tablet coating.   
 
Amongst the materials under evaluation, ethylcellulose, an insoluble tablet coating material, 
exhibited one of the lowest resistance-to-movement values, presumably by providing a smooth 195 
water-repellent coating to glass disc that glides on interfacial water. Similarly, coatings of sorbitan 
monopalmitate, a sparingly water soluble hydrophobic surfactant with a low HLB value (6.7) also 
showed a very reduced resistant to movement across the mucosa. The hypothesis of the lubricant 
effect of interfacial water was further tested with paraffin wax (Drake et al., 2002). As expected, the 
maximum detachment force and corresponding work done were directionally lower but not 200 
significantly different (Multiple comparison - Tukey's HSD, p < 0.05) to those obtained with the 
uncoated glass disc. 
 
The incorporation of a plasticizer (e.g. triacetin; commonly used in pharmaceutical coatings) in 
HPMC (Table 5, Fig. 6) or the mixing of HPMC with a low molecular weight PEG or with a pluronic 205 
surfactant did not alter the bioadhesive properties of corresponding coatings. 
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This work evaluated a range of coating materials for their capability to influence the residence time 
of a solid dosage form in the oesophagus. A lipophilic surfactant and a water-insoluble polymer have 
been shown to promote rapid transit, suggesting their suitability as candidate coating materials for 210 
easy-to-swallow solid oral formulations. By contrast, known mucoadhesive materials used as 
coatings slowed the transit of a coated modelled tablet.  The work identifies promising oesophageal 
coating materials, especially for easy-to-swallow solid dosage forms.  
 
References 215 
Arciola, C.R.,  Campoccia, D, Speziale, P, Montanaro, L, Costerton JW. 2012. Biofilm formation in 
Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-
resistant materials Biomaterials 33, 5967 – 5982. 
Batchelor, H.K., Banning, D., Dettmar, P.W., Hampson, F.C., Jolliffe, I.G., Craig, D.Q.M. 2002. An in 
vitro mucosal model for the prediction of the bioadhesion of alginate solutions to the oesophagus. 220 
Int. J. Pharm. 238, 123-132. 
Channer K.S. and Virjee J.P. 1985. The effect of formulation of oesophageal transit J. Pharm. 
Pharmacol. 37, 126-129 
Collaud, S., Warloe, T., Jordan, O., Gurny, R., Lange, N. 2007. Clinical evaluation of bioadhesive 
hydrogels for the topical delivery of hexylaminolevulinate to Barrett’s esophagus. J. Contr. Rel. 123, 225 
203-210. 
Drake, W.M., Worsley, D.F., Lentle, B.C., Kendler, D.L. 2002.  Monitoring Esophogeal trasit of wax-
polished alendronate in healthy post-menopausal women: a new technique to study of pill transit 
time. Current therapeutic research 63, 103-109. 
Hill, L.L., Woodruff, L.H., Foote, J.C., Barreto-Alcoba, M.A. 2005. Esophageal injury by apple cider 230 
vinegar tablets and subsequent evaluation of products. J. Amer. Dietet. Assoc. 105, 1141-1143. 
 10 
Mako, A., Csoka, G., Pasztor, E., Marton, S., Horvai, G., Klebovich, I. 2009. Formulation of 
thermoresponsive and bioadhesive gel for the treatment of oesophageal pain and inflammation. 
Europ J. Pharm Biopharm. 72, 260-265. 
Mortazavi, S.A., Smart J.D. 1995. An assessment of some factors influencing the in vitro assessment 235 
of mucoadhesion. Int. J. Pharm. 116, 223-230.  
Jaspersen, D. 2000. Drug induced oesophageal disorders. Drug Safety. 22(3): 237-249 
Marvola, M. Rajaniemi, M., Marttila, E., Vahervuo, K., Sothmann, A. 1982. Effect of dosage form and 
formulation factors on the adherence of drugs to the oesophagus. J. Pharm. Sci. 71(9): 975-977 
Perkins, A.C., Wilson, C.G., Frier, M., Blackshaw, P.E., Dansereau, R.J., Vincent, R.M., Wenderoth, D., 240 
Hathaway, S., LI, Z., Spiller, R.C. 2001.  The use of scintigraphy to demonstrate the rapid esophageal 
transit of the oval film coated placebo risedronate tablet compared to a round uncoated placebo 
tablet when administered with minimal volumes of water. Int. J. Pharm. 222, 295-303. 
Smart, J.D.,   Dunkley, S.,  Tsibouklis, J., Young, S. 2013. An in vitro model for the evaluation of the 
adhesion of solid oral dosage forms to the oesophagus. Int. J. Pharm. 447, 199 – 203. 245 
Smart J.D. Theories of muoadhesion. In Mucoadhesive Materials and Drug Delivery Systems Ed.  V. 
Khutoryanskiy John Wiley & Sons Ltd, Chichester 2014 pp159-174. 
Ueda, K., Muto, M., Chiba, T. 2011. A case of esophageal ulcer caused by alendronate sodium 
tablets. Gastrointestinal endoscopy 73, 1037. 
Table 1. Average work done (WD) and maximum detachment forces (MDF) for polymer coatings 250 
relative to rouqhened qlass controls, evaluated in the in vitro test system. 
 
 
 
Material  Film weight 
/ mg (s.d.) 
WD /μJ (n = 6) s.d.  MDF / mN 
(n = 6) 
s.d.  
 11 
Sodium alginate  1.96 (0.09)  4154.03  1379.01  263.42  111.39  
Glass control   666.35  72.71  13.72  1 .11  
HPMC  1.73 (0.18)  1209.28  339.70  95.14  43.68  
Glass control   665.01  118.83  14.52  2.52  
LustreClear  1.74 (0.04)  900.91  44.45  71.52  32.46  
Glass control   801.25  127.64  17.31  2.26  
PVA  1.92 (0.10)  625.23  57.00  29.11  8.36  
Glass control   628.94  73.54  13.44  2.99  
Gelatin 1.89 (0.20)  575.25  76.02  19.83  7.61  
Glass control   605.51  70.79  12.58  2.03  
 255 
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Table 2. Average work done (WD) and maximum detachment forces (MDF) for polyoxyethylene 
polymer coatings relative to rouqhened qlass controls evaluated in the in vitro test system.  
Material  Film weight 
/ mg (s.d.) 
WD /μJ (n = 6) s.d.  MDF / 
mN (n = 
6) 
s.d.  
PolyOx  1.98 (0.15)  744.51  80.71  48.98  16.34  
Glass control   705.08  47.05  14.77  0.70  
PEG 1,450 
(solution)  
1.90 (0.70)  653.96  91.05  14.37  2.47  
Glass control   586.04  71.61  13.00  1.57  
PEG 1,450 (Melt)  3.26 (0.15)  611.23  74.51  16.66  1.80  
Glass control   559.70  47.38  12.35  2.38  
PEG 6,000  1.83 (0.16)  591.50  98.85  12.70  1.84  
Glass control   585.49  54.69  12.86  2.05  
 260 
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Table 3. Average work done (WD) and maximum detachment forces (MDF) for Pluronic""" 
copolymers coatings relative to rouqhened qlass controls evaluated in the in vitro test system.  
Material  Film weight 
/ mg (s.d.) 
WD /μJ (n = 6) s.d.  MDF / mN 
(n = 6) 
s.d.  
F127 1.82 (0.17)  1121.57  361.05  81.85  37.57  
Glass control   526.20  59.86  11.56  1.92  
F98 1.88 (0.18)  782.82  83.72  48.67  14.67  
Glass control   480.26  59.94  9.98  1.11  
F38  1.81 (0.18)  572.16  65.89  13.19  2.34  
Glass control   575.21  85.14  12.49  2.33  
PVA/F127  1.67 (0.20)  505.29  43.09  20.36  5.21  
Glass control   513.65  92.52  10.78  1.84  
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Table 4. Average work done (WD) and maximum detachment force (MDF) values for 
Hydrophobic coatings and rouqhened qlass controls evaluated in the in vitro test system.  
Material  Film weight 
/ mg (s.d.) 
WD /μJ (n = 6) s.d.  MDF / mN 
(n = 6) 
s.d.  
Ethylcellulose  1.76 (0.23)  438.52  22.72  8.59  0.59  
Glass control   734.46  59.01  16.01  2.03  
Paraffin wax  3.5 (0.20)  416.44  54.84  8.61  1.35  
Glass control   532.32  57.52  10.60  1.42  
Sorbitan 
monopalmitate  
1.98 (0.20)  339.01  29.82  7.01  0.85  
Glass control   608.10  89.89  13.07  2.05  
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Table 5. Average work done (WD) and maximum detachment force (MDF) values for polymer blend 270 
coatings relative to rouqhened qlass controls evaluated in the in vitro test system. 
Material  Film 
weight / 
mg (s.d.) 
WD /μJ (n = 6) s.d.  MDF / mN 
(n = 6) 
s.d.  
HPMC/triacetin (2: 1)  1.93 (0.32)  1095.91  338.49  51.46  22.70  
Glass control   570.00  43.67  12.09  1.32  
HPMC/triacetin (5:1)  1.86 (0.17)  1244.75  275.32  108.49  35.00  
Glass control   603.48  75.18  13.21  3.18  
HPMC/PEG 200  1.72 (0.27)  1196.05  169.03  74.05  18.72  
Glass control   688.51  37.50  15.71  0.90  
HPMC/triacetin/F127  1.93 (0.14)  1297.67  281.96  77.64  29.53  
Glass control   625.60  109.85  13.71  2.35  
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Fig. 1. Schematic diagram of the in vitro oesophageal adhesion model 
Fig. 2. Adhesion and detachment ratios calculated for various coating materials  evaluated in the in 275 
vitro test system (n = 6).  
Fig. 3.Adhesion and detachment rations for the hydrophilic polymers (n=6) 
Fig. 4. Adhesion and detachment rations for the pluronic polymers (n=6) 
Fig. 5. Adhesion and detachment rations for the hydrophobic/insoluble polymers (n=6) 
Figure 6. Adhesion and detachment ratios calculated for polymer blends relative to HPMC evaluated 280 
in the in vitro test system (n = 6).  
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